Table 1 Demographic parameters of the MS patients, disease characteristics and medications.

From: Machine-learning based lipid mediator serum concentration patterns allow identification of multiple sclerosis patients with high accuracy

 

MS 1st course

RRMS no relapse

RRMS acute relapse

SPMS or PPMS

Mean

SD

n

Mean

SD

n

Mean

SD

n

Mean

SD

n

Mean

SD

n

Mean

SD

n

Mean

SD

n

Mean

SD

n

Sex

m

  

f

  

m

  

f

  

m

  

f

  

m

  

f

  

Age

38.2

7.5

8

31.6

9.1

12

35.5

9.4

16

34.3

8.9

39

33.8

7.0

4

37.2

10.9

18

43.6

18.1

3

49.2

11.0

2

Disease years

0.03

0.04

 

0.9

2.9

 

7.5

6.1

 

7.4

5.9

 

2.1

1.8

 

6.7

5.3

 

5.7

4.7

 

1.0

1.3

 

EDSS

0.6

1.0

 

0.8

1.1

 

3.1

1.7

 

2.3

1.6

 

1.63

1.2

 

2.0

1.9

 

4.0

2.8

 

5.0

  

Medication

   None

  

6

  

11

  

3

  

6

  

1

  

10

  

1

  

1

   β-Interferon

  

0

  

0

  

6

  

11

  

2

  

5

  

0

  

1

   Fingolimod

  

0

  

0

  

3

  

5

  

0

  

1

  

1

  

0

   Natalizumab

  

0

  

0

  

4

  

15

  

0

  

0

  

0

  

0

   Other

  

2

  

1

  

0

  

2

  

1

  

2

  

1

  

0

  1. EDSS: Expanded Disability Status Scale, RRMS: Relapsing Remitting MS, PPMS: Primary Progressive MS, SPMS: Secondary Progressive MS.
Back to article page